Frontiers | The Macrophage Response to Mycobacterium tuberculosis and Opportunities for Autophagy Inducing Nanomedicines for Tuberculosis Therapy
Dr. Bhawani Shankar - Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (MTB) bacteria. Tuberculosis generally affects the lungs, but can also affect other parts of the body. Some symptoms
Tuberculosis - Wikipedia
Immunopathogenic overlap between COVID-19 and tuberculosis identified from transcriptomic meta-analysis and human macrophage infection - ScienceDirect
Early innate and adaptive immune perturbations determine long-term severity of chronic virus and Mycobacterium tuberculosis coinfection - ScienceDirect
Pathogens | Free Full-Text | Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome—An Extempore Game of Misfiring with Defense Arsenals
Frontiers | Granulomas and Inflammation: Host-Directed Therapies for Tuberculosis
Mycobacterium tuberculosis (MTB)
TBRU-ASTRa Objective
Opening Pandora's Box: Mechanisms of Mycobacterium tuberculosis Resuscitation: Trends in Microbiology
Mind the gap – Managing tuberculosis across the disease spectrum - eBioMedicine
Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation study - The Lancet Infectious Diseases
Targeting immunometabolism in host defence against Mycobacterium tuberculosis - Sheedy - 2021 - Immunology - Wiley Online Library
Frontiers | Defining the role of neutrophils in the lung during infection: Implications for tuberculosis disease
Patterns of T and B cell responses to Mycobacterium tuberculosis membrane-associated antigens and their relationship with disease activity in rheumatoid arthritis patients with latent tuberculosis infection | PLOS ONE
The emerging role of exosomal miRNAs as a diagnostic and therapeutic biomarker in Mycobacterium tuberculosis infection | Molecular Medicine | Full Text